- Headquarters
- Cambridge
- Employees
- 51–200
- Founded
- 2013
- Business Model
- B2B
- Website
- biomodal.com
- Last Round
- Series DNov 2021
- Rounds
- 3
About
biomodal creates technologies that bring the dynamism of our ever-changing biology into focus.
Summary
biomodal is a Biotech company based in Cambridge, United Kingdom, founded in 2013. Its most recent funding was a Series D round in Nov 2021. Investors include Temasek, GV (Google Ventures) and Third Point Ventures.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Nov 2021
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Novel DNA sequencing architecture to scale the ultra low cost whole genome
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Long-read DNA sequencing company providing advanced systems for complete and accurate genome, tra...
Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...
Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...
Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...